COMPARISON OF BIVALIRUDIN VERSUS HEPARIN PLUS GLYCOPROTEIN IIB/IIIA INHIBITORS IN PATIENTS UNDERGOING AN INVASIVE STRATEGY: A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS